598 related articles for article (PubMed ID: 27131608)
21. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
22. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
Nair A; Vyas H; Shah J; Kumar A
Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
[TBL] [Abstract][Full Text] [Related]
23. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.
Vora LK; Donnelly RF; Larrañeta E; González-Vázquez P; Thakur RRS; Vavia PR
J Control Release; 2017 Nov; 265():93-101. PubMed ID: 29037785
[TBL] [Abstract][Full Text] [Related]
24. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
25. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
[TBL] [Abstract][Full Text] [Related]
26. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
Yang Y; Xie XY; Mei XG
Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
[TBL] [Abstract][Full Text] [Related]
27. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
[TBL] [Abstract][Full Text] [Related]
28. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
29. Development of PLGA nanoparticles loaded with clofazimine for oral delivery: Assessment of formulation variables and intestinal permeability.
Chaves LL; Costa Lima SA; Vieira ACC; Barreiros L; Segundo MA; Ferreira D; Sarmento B; Reis S
Eur J Pharm Sci; 2018 Jan; 112():28-37. PubMed ID: 29122712
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous penetration of soft nanoparticles via photodamaged skin: Lipid-based and polymer-based nanocarriers for drug delivery.
Hung CF; Chen WY; Hsu CY; Aljuffali IA; Shih HC; Fang JY
Eur J Pharm Biopharm; 2015 Aug; 94():94-105. PubMed ID: 25986584
[TBL] [Abstract][Full Text] [Related]
31. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
Mistry NP; Desai JL; Thakkar HP
J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
[TBL] [Abstract][Full Text] [Related]
32. Possibility for the development of cosmetics with PLGA nanospheres.
Ito F; Takahashi T; Kanamura K; Kawakami H
Drug Dev Ind Pharm; 2013 May; 39(5):752-61. PubMed ID: 22725249
[TBL] [Abstract][Full Text] [Related]
33. Investigation of microemulsion microstructure and its impact on skin delivery of flufenamic acid.
Mahrhauser DS; Kählig H; Partyka-Jankowska E; Peterlik H; Binder L; Kwizda K; Valenta C
Int J Pharm; 2015 Jul; 490(1-2):292-7. PubMed ID: 26022888
[TBL] [Abstract][Full Text] [Related]
34. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery.
Song J; Fan X; Shen Q
Int J Pharm; 2016 Mar; 501(1-2):245-52. PubMed ID: 26851353
[TBL] [Abstract][Full Text] [Related]
35. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.
Le Broc-Ryckewaert D; Carpentier R; Lipka E; Daher S; Vaccher C; Betbeder D; Furman C
Int J Pharm; 2013 Oct; 454(2):712-9. PubMed ID: 23707251
[TBL] [Abstract][Full Text] [Related]
36. Iontophoretic transdermal delivery of glycyrrhizin: effects of pH, drug concentration, co-ions, current intensity, and chemical enhancers.
Yamamoto R; Takasuga S; Kominami K; Sutoh C; Kinoshita M; Kanamura K; Takayama K
Chem Pharm Bull (Tokyo); 2013; 61(12):1275-81. PubMed ID: 24292789
[TBL] [Abstract][Full Text] [Related]
37. Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen.
Shah PP; Desai PR; Singh M
J Control Release; 2012 Mar; 158(2):336-45. PubMed ID: 22134117
[TBL] [Abstract][Full Text] [Related]
38. Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats.
Patel N; Jain S; Lin S
Int J Pharm; 2016 Nov; 513(1-2):393-403. PubMed ID: 27633278
[TBL] [Abstract][Full Text] [Related]
39. Combined effect of PLGA and curcumin on wound healing activity.
Chereddy KK; Coco R; Memvanga PB; Ucakar B; des Rieux A; Vandermeulen G; Préat V
J Control Release; 2013 Oct; 171(2):208-15. PubMed ID: 23891622
[TBL] [Abstract][Full Text] [Related]
40. Transdermal iontophoretic delivery of a liquid lipophilic drug by complexation with an anionic cyclodextrin.
Juluri A; Narasimha Murthy S
J Control Release; 2014 Sep; 189():11-8. PubMed ID: 24950431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
